MBB Public Markets’s Exact Sciences EXAS Stock Holding History

MBB Public Markets’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-13,300	Closed	-$562K	–	615
2024 Q2	$562K	Buy	+13,300	New	+$732K	0.01%	637

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

MBB Public Markets's EXAS Position: Q3 2024 in Review

MBB Public Markets sold out of Exact Sciences (EXAS) in Q3 2024, closing a stake of 13,300 shares — an estimated $562K sold.

MBB Public Markets first reported a position in EXAS in Q2 2024 and held it in 1 quarter. The position peaked at $562K in Q2 2024. 599 funds tracked by Wall St. Rank hold EXAS as of Q3 2024.

MBB Public Markets reported no remaining Exact Sciences position as of Q3 2024 after selling out during the quarter.
MBB Public Markets sold 13,300 Exact Sciences shares in Q3 2024, an estimated $562K.
MBB Public Markets first reported a position in Exact Sciences in Q2 2024 and held it in 1 quarter.
MBB Public Markets's Exact Sciences position peaked at $562K in Q2 2024.
599 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2024.

Based on MBB Public Markets's 13F filing for Q3 2024, filed 14 Nov 2024.